Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -17 of 17 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/12/2007 First Published: 3/1/2000


11.		Phase II Study of Induction Therapy With Docetaxel and Doxorubicin Followed By Sequential High Dose Chemotherapy and CD34+ Selected Peripheral Blood Stem Cell Support in Women With Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 65				NCI				NU-H97B1 NCI-G00-1682, NCT00004906

Last Modified: 11/12/2007 First Published: 10/25/2003


12.		Phase II Neoadjuvant/Adjuvant Study of Pamidronate With Standard Induction and Maintenance Chemotherapy in Patients With Newly Diagnosed High-Grade Osteosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Any age				NCI				MSKCC-03074 NCT00072306


13.		Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				UARK 98-036 NCT00083382


14.		Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Other				UARK 99-016 NCT00083408

Last Modified: 8/15/2007 First Published: 7/22/2005


15.		Phase I Study of Arsenic Trioxide and Pamidronate in Patients With Advanced Solid Tumors or Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				CCC-PHI-45 6458, NCI-6458, NCT00124605

Last Modified: 11/12/2007


16.		Randomized Placebo-Controlled Study of Pamidronate for the Prevention of Skeletal-Related Complications in Patients with Breast Cancer and Lytic Bone Lesions Treated with Hormonal Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Closed				18 and over								CG-AREDIA-18 NCI-V92-0040

Last Modified: 11/12/2007


17.		Randomized Placebo-Controlled Study of Pamidronate for the Prevention of Skeletal-Related Complications in Patients with Breast Cancer and Lytic Bone Lesions Treated with Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Closed				18 and over								CG-AREDIA-19 NCI-V92-0041

Select All on One Page


					< Previous 1 2